Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (새로운 창 열기)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Source‎: Br J Haematol. 2022;197(3):359-66.

Indexed‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (새로운 창 열기)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (새로운 창 열기)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Source‎: Br J Haematol 1998;103(4):1061-3.

Indexed‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (새로운 창 열기)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (새로운 창 열기)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Source‎: Ann Intern Med 2007;146(1):25-33.

Indexed‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (새로운 창 열기)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (새로운 창 열기)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Source‎: Lancet Haematol 2020;7(9):e640-8.

Indexed‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (새로운 창 열기)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (새로운 창 열기)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Source‎: J Pediatr 1993;123(6):989-95.

Indexed‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (새로운 창 열기)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (새로운 창 열기)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Source‎: Ann Hematol 2004;83(12):764-8.

Indexed‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (새로운 창 열기)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (새로운 창 열기)

British Committee for Standards in Haematology General Haematology Task Force.

Source‎: Br J Haematol 2003;120(4):574-96.

Indexed‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (새로운 창 열기)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (새로운 창 열기)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Source‎: Blood Adv 2020;4(7):1492-1500.

Indexed‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (새로운 창 열기)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (새로운 창 열기)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Source‎: N Engl J Med 2003;349(9):831-6.

Indexed‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (새로운 창 열기)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (새로운 창 열기)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Source‎: Blood 2012;120(5):960-9.

Indexed‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (새로운 창 열기)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (새로운 창 열기)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Source‎: Br J Haematol 2017;178(6):959-70.

Indexed‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (새로운 창 열기)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (새로운 창 열기)

Kojouri K, Vesely SK, Terrell DR, George JN.

Source‎: Blood 2004;104(9):2623-34.

Indexed‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (새로운 창 열기)

Romiplostim or standard of care in patients with immune thrombocytopenia. (새로운 창 열기)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Source‎: N Engl J Med 2010;363(20):1889-99.

Indexed‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (새로운 창 열기)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (새로운 창 열기)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Source‎: Blood 2007;109(4):1401-7.

Indexed‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (새로운 창 열기)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (새로운 창 열기)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Source‎: Blood 2011;117(16):4190-207.

Indexed‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (새로운 창 열기)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (새로운 창 열기)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Source‎: Blood Adv 2019;3(23):3829-66.

Indexed‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (새로운 창 열기)

International consensus report on the investigation and management of primary immune thrombocytopenia. (새로운 창 열기)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Source‎: Blood 2010;115(2):168-86.

Indexed‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (새로운 창 열기)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (새로운 창 열기)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Source‎: Blood 1997;89(8):2689-700.

Indexed‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (새로운 창 열기)